Home Newsfeeds DICE Therapeutics Q2 EPS $(0.58)

DICE Therapeutics Q2 EPS $(0.58)

DICE Therapeutics (NASDAQ:DICE) reported quarterly losses of $(0.58) per share.

byBenzinga Newsdesk

August 11, 2022

1 minute read

DICE Therapeutics (NASDAQ:DICE) reported quarterly losses of $(0.58) per share.

General
News

ABB Ramps Up Investment In Its Robotics Facility In US

By Shivani Kumaresan

March 16, 12:31 PM

ABB Ltd (NYSE:ABB) said it is expanding its existing North American robotics headquarters and manufacturing facility in Auburn Hills, Michigan.…

ABB

Miners Cheer As China’s Manufacturers Continue To Increase Pace

By Neil Dennis

April 1, 2:07 PM

Iron ore prices rise in Asia on China's manufacturing growth, but construction remains a concern. Steel stocks reflect mixed performance.

FCX

Ermenegildo Zegna Group Earlier Reported Q3 2023 Results; Revenue Of €431M Up 20.8% YoY

By Benzinga Newsdesk

October 24, 1:05 PM

Revenues1 for the third quarter of 2023 reach €431 million, up 20.8% year-over-year and with an organic2 growth rate of 11.3%.Revenues for the first nine months of 2023 reach €1.33 billion, up 22.9% year-over-year and

ZGN

Elbit Systems Awarded $76M Contract to Supply Electronic Warfare Training Capability to a Country in Asia-Pacific

By Charles Gross

September 13, 4:40 AM

Elbit Systems Ltd. (NASDAQ: ESLT) announced today that it was awarded a contract valued at approximately $76 million to supply an Electronic Warfare (EW) training capability to the Air Force of a country in Asia-Pacific. The contract will be performed over a period of two years.

ESLT

DICE Therapeutics Q2 EPS $(0.58)

Related Posts

ABB Ramps Up Investment In Its Robotics Facility In US

Miners Cheer As China’s Manufacturers Continue To Increase Pace

Ermenegildo Zegna Group Earlier Reported Q3 2023 Results; Revenue Of €431M Up 20.8% YoY

Elbit Systems Awarded $76M Contract to Supply Electronic Warfare Training Capability to a Country in Asia-Pacific